Lysophospholipids Enhance Matrix Metalloproteinase-2 Expression in Human Endothelial Cells
- 1 August 2005
- journal article
- Published by The Endocrine Society in Endocrinology
- Vol. 146 (8) , 3387-3400
- https://doi.org/10.1210/en.2004-1654
Abstract
Lysophosphatidic acid (LPA) and sphingosine 1-phosphate (S1P) are both low-molecular-weight lysophospholipids, which promote cell proliferation, migration, and invasion via interaction with a family of specific G protein-coupled receptors. Matrix metalloproteinases (MMPs) are zinc-dependent proteolytic enzymes, which are involved in degradation of the extracellular matrix and play critical roles in endothelial cell migration and matrix remodeling during angiogenesis. Among these MMPs, MMP-2 is known to trigger cell migration. In our present study, we examined the effects of LPA and S1P on MMP-2 expression in human endothelial cells. We showed that LPA and S1P enhanced MMP-2 expression in mRNA, protein levels, and also enzymatic activity of cells of the EAhy926 human endothelial cell line. The enhancement effects occurred in concentration- and time-dependent manners. Results from real-time PCR, Western blots, and substrate gels indicated that these enhancement effects were mediated through MAPK kinase/ERK-, nuclear factor-κB-, and calcium influx-dependent pathways. Furthermore, we show that endothelial cell invasion of the gel was enhanced by lysophospholipids, and the induction could be prevented by an MMP inhibitor, GM6001. These observations suggest that LPA and S1P may play important roles in endothelial cell invasion by regulating the expression of MMP-2.Keywords
This publication has 60 references indexed in Scilit:
- Lysophospholipid regulation of mononuclear phagocytesBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2002
- Lysophosphatidic acid as an autocrine and paracrine mediatorBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2002
- Phorbol 12-Myristate 13-Acetate Stimulates Lysophosphatidic Acid Secretion from Ovarian and Cervical Cancer Cells but Not from Breast or Leukemia CellsGynecologic Oncology, 1998
- Recombinant Human G Protein-Coupled Lysophosphatidic Acid Receptors Mediate Intracellular Calcium MobilizationMolecular Pharmacology, 1998
- Lysophosphatidic Acid as a Potential Biomarker for Ovarian and Other Gynecologic CancersJAMA, 1998
- Matrix Metalloproteinase Stromelysin-1 Triggers a Cascade of Molecular Alterations That Leads to Stable Epithelial-to-Mesenchymal Conversion and a Premalignant Phenotype in Mammary Epithelial CellsThe Journal of cell biology, 1997
- Lysophosphatidic acid as a phospholipid mediator: pathways of synthesisFEBS Letters, 1997
- Sphingolipid metabolism and cell growth regulationThe FASEB Journal, 1996
- Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cellsCell, 1995
- Identification of the molecular species of lysophosphatidic acid produced when platelets are stimulated by thrombinBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1989